Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | GILD | VRTX | REGN |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 146.37 | 266.83 | 67.80 | 396.88 | 897.22 |
| High | 148.44 | 267.51 | 67.89 | 398.49 | 901.07 |
| Low | 146.01 | 263.81 | 67.19 | 393.53 | 890.43 |
| Last | 147.50 | 265.19 | 67.54 | 395.57 | 895.71 |
| Change | -0.20 | -0.32 | -0.21 | -1.79 | -2.85 |
| % Change | -0.14% | -0.12% | -0.31% | -0.45% | -0.32% |
| Volume | 43,813 | 504,989 | 1,408,403 | 177,048 | 171,938 |
| 20-Day Average Volume | 518,707 | 2,191,607 | 6,242,272 | 874,122 | 412,388 |
| Previous Close | 147.70 | 265.51 | 67.75 | 397.36 | 898.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 150.85 | 273.78 | 70.93 | 408.71 | 945.50 |
| 20-Day Raw Stochastic | 21.14% | 0.69% | 3.04% | 8.49% | 3.79% |
| 20-Day Relative Strength | 40.68% | 37.57% | 30.82% | 38.12% | 31.71% |
| Weighted Alpha | -30.72 | +4.94 | -23.31 | +16.61 | +11.91 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 96% Sell | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 72% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.72% since 04/09/24 | -2.36% since 04/09/24 | -3.64% since 04/09/24 | -2.12% since 04/09/24 | -5.31% since 04/09/24 |
| Low | 146.01 on 04/16/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 393.53 on 04/16/24 | 890.43 on 04/16/24 |
| High | 154.96 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 | 937.87 on 04/10/24 |
| 1-Month | |||||
| %Chg | -1.54% since 03/15/24 | -1.82% since 03/15/24 | -8.54% since 03/15/24 | -2.89% since 03/15/24 | -7.33% since 03/15/24 |
| Low | 143.66 on 03/22/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 393.53 on 04/16/24 | 890.43 on 04/16/24 |
| High | 159.34 on 04/09/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -21.61% since 01/16/24 | -13.02% since 01/16/24 | -21.62% since 01/16/24 | -9.51% since 01/16/24 | -4.64% since 01/16/24 |
| Low | 143.52 on 02/15/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 393.53 on 04/16/24 | 890.43 on 04/16/24 |
| High | 191.72 on 01/24/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -12.12% since 10/16/23 | -7.98% since 10/16/23 | -14.90% since 10/16/23 | +5.86% since 10/16/23 | +5.94% since 10/16/23 |
| Low | 143.52 on 02/15/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,602,222 | 142,291,856 | 84,353,968 | 102,701,272 | 98,627,744 |
| Shares Outstanding, K | 125,946 | 535,919 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 439,720,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -137,870,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.39 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/15/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 29.51 | 24.07 |